VIH y COVID-19: Una revisión narrativa rápida.

Main Article Content

Alberto Farias Aguilera

Abstract

Introducción: El impacto del SARS-CoV-2 en la pandemia del VIH, era desconocido en enero del 2020, pero transcurridos casi seis meses de la aparición del COVID-19, ya contamos con variadas publicaciones académicas de esta sindemia.


El presente artículo es una revisión narrativa rápida de la literatura científica actual sobre VIH y COVID-19.


Metodología: Se revisaron publicaciones en buscadores académicos a mediados de mayo del 2020 sobre VIH y COVID-19.


Se encontraron editoriales y cartas al editor, correspondencia, viewpoint, artículos originales [algunos pre-print], notas de campo y comentarios. Todos con valiosa información clínica sobre la relación entre ambas epidemias.


Desarrollo: Se clasificaron las publicaciones temáticamente en: respuesta clínica de personas VIH positivas afectadas por el COVID-19, farmacología, mantención y adaptación de los servicios de salud sexual, lecciones del VIH para la respuesta al COVID-19, poblaciones clave, efectos psicosociales, estigma y discriminación. 


Conclusiones: No hay evidencia de que personas VIH positivas, en TARV y por tanto, sin compromiso inmune, tengan mayor riesgo de COVID-19; tampoco en personas en etapa SIDA.


Sí hay evidencia de mayor riesgo con edad avanzada y comorbilidades. No hay evidencia que sostenga que el TARV es efectivo para el SARS-CoV-2.


Los servicios de salud sexual pueden y deben adaptarse a la contingencia. El VIH entrega importantes lecciones para la respuesta al COVID-19. Las poblaciones clave, requieren especial protección.


Los efectos psicosociales y el estigma y la discriminación del COVID-19 y el VIH, generan impactos en la respuesta de la epidemia.

Downloads

Download data is not yet available.

Article Details

How to Cite
Farias Aguilera, A. (2021). VIH y COVID-19: Una revisión narrativa rápida. Nursing Care and Health Education, 6(1), 103–118. https://doi.org/10.15443/ceyes.v6i1.1317
Section
Artículos Originales

References

Kenmoe S, Bigna J, Fatawou

Modiyingi A, Ndangang M, Ngoupo P,

Simo F et al. Case fatality rate and viral

aetiologies of acute respiratory tract

infections in HIV positive and negative

people in Africa: The VARIAFRICAHIV systematic review and metaanalysis. Journal of Clinical Virology.

; 117: 96-102.

https://doi.org/10.1016/j.jcv.2019.06.

Villamil-Gómez W, Sánchez Á, Gelis

L, Silvera L, Barbosa J, Otero-Nader O

et al. Fatal human coronavirus 229E

(HCoV-229E) and RSV–Related

pneumonia in an AIDS patient from

Colombia. Travel Medicine and

Infectious Disease. 2020;

https://doi.org/10.1016/j.tmaid.2020.1

Center for Disease Control [CDC].

What to know about HIV and COVID19. 2020 [cited 14 June 2020].

Available from:

https://www.cdc.gov/coronavirus/201

-ncov/need-extraprecautions/hiv.html

Yang R, Gui X, Gao S, et al. The

reflection on an AIDS patient with

asymptomatic COVID-19. Research

Square [preprint]. 2020.

DOI: 10.21203/rs.3.rs-18738/v1

Favas, C. Guidance for the prevention

of COVID-19 infections among high

risk individuals in camps and camp

like settings. London School of

Hygiene & Tropical Medicine. 31

March 2020 [cited 11 June 2020].

Available from:

https://www.alnap.org/helplibrary/guidance-for-the-preventionof-covid-19-infection-among-highrisk-individuals-in-camps

Moni M, Liò P. Network-based

analysis of comorbidities risk during

an infection: SARS and HIV case studies. BMC Bioinformatics.

;15(1):1-23.

https://doi.org/10.1186/1471-2105-

-333

Gervasoni C, Meraviglia P, Riva A,

Giacomelli A, Oreni L, Minisci D et al.

Clinical features and outcomes of HIV

patients with coronavirus disease

Clinical Infectious Diseases

[preprint]. 2020 [cited 7 June 2020].

Available from:

https://pubmed.ncbi.nlm.nih.gov/3240

/

Härter, G., Spinner, C.D., Roider, J. et

al. COVID-19 in people living with

human immunodeficiency virus: a case

series of 33 patients. Infection (2020).

https://doi.org/10.1007/s15010-020-

-z

Wu Q, Chen T, Zhang H. Recovery

from COVID-19 in two patients with

coexisted HIV infection. J Med Virol

[preprint]. 2020 [cited 7 June 2020].

Recuperado de:

https://doi.org/10.1002/jmv.26006

Blanco J, Ambrosioni J, Garcia F,

Martínez E, Soriano A, Mallolas J et

al. COVID-19 in patients with HIV:

clinical case series. The Lancet HIV.

;7(5): e314-e316.

https://doi.org/10.1016/S2352-

(20)30111-9

Altuntas Aydin O, Kumbasar

Karaosmanoglu H, Kart Yasar K.

HIV/SARS‐CoV‐2 coinfected patients

in Istanbul, Turkey. Journal of Medical

Virology [Internet]. 2020 [cited 8 June

;1-3.

https://doi.org/10.1002/jmv.25955

Laurence J. Why Aren't People Living

with HIV at Higher Risk for

Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS

Patient Care and STDs.

;34(6):247-248.

https://doi.org/10.1089/apc.2020.2900

com

Zhao J, Liao X, Wang H, et al. Early

virus clearance and delayed antibody

response in a case of COVID-19 with

a history of co-infection with HIV-1

and HCV [published online ahead of

print, 2020 Apr 9]. Clin Infect Dis.

; ciaa408.

https://doi.org/10.1093/cid/ciaa408

Guo, Wei and Ming, Fangzhao and

Dong, Yu and Zhang, Qian and Zhang,

Xiaoxia and Mo, Pingzheng and Feng,

Yong and Liang, Ke. A Survey for

COVID-19 Among HIV/AIDS

Patients in Two Districts of Wuhan,

China. The Lancet [preprint].

Available at

http://dx.doi.org/10.2139/ssrn.355002

Cao B, Wang Y, Wen D, Liu W, Wang

J, Fan G et al. A Trial of Lopinavir–

Ritonavir in Adults Hospitalized with

Severe Covid-19. New England

Journal of Medicine.

;382(19):1787-1799. DOI:

1056/NEJMoa2001282

Copertino Jr. D, Lima B, Duarte R,

Wilkin T, Gulick R, de Mulder

Rougvie M et al. Antiretroviral Drug

Activity and Potential for PreExposure Prophylaxis Against

COVID-19 and HIV Infection.

ChemRxiv [preprint]. 2020 [cited 8

June 2020]. Available from:

https://chemrxiv.org/articles/Antiretro

viral_Drug_Activity_and_Potential_f

or_PreExposure_Prophylaxis_Against_COVID19_and_HIV_Infection/12250199/

?file=22537484

Mitjà O, Clotet B. Use of antiviral

drugs to reduce COVID-19

transmission. The Lancet Global

Health. 2020;8(5): e639-e640.

https://doi.org/10.1016/S2214-

X(20)30114-5

Lack of evidence to support use of

darunavir-based treatments for SARSCoV-2 [Internet]. Janssen UK. 2020

[cited 15 June 2020]. Available from:

https://www.janssen.com/uk/sars-cov2-treatment

Nyoni, T., Okumu, M. COVID-19-

Compliant Strategies for Supporting

Treatment Adherence Among People

Living with HIV in Sub-Saharan

Africa. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-0

Lodge W, Kuchukhidze S. COVID-19,

HIV, and Migrant Workers: The

Double Burden of the Two Viruses.

AIDS Patient Care and STDs.

;34(6):249-250. DOI:

https://doi.org/10.1089/apc.2020.0092

Shiau, S., Krause, K.D., Valera, P. et

al. The Burden of COVID-19 in

People Living with HIV: A Syndemic

Perspective. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-9

Jiang H, Zhou Y, Tang W. Maintaining

HIV care during the COVID-19

pandemic. The Lancet HIV. 2020;7(5):

e308-e309.

https://doi.org/10.1016/S2352-

(20)30105-3

Stanford, K.A., Friedman, E.E.,

Schmitt, J. et al. Routine Screening for

HIV in an Urban Emergency Department During the COVID-19

Pandemic. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-x

Nosyk B, Armstrong W, del Rio C.

Contact tracing for COVID-19: An

opportunity to reduce health disparities

and End the HIV/AIDS Epidemic in

the US. Clinical Infectious Diseases

[preprint]. 2020 [cited 7 June 2020].

Available from:

https://www.ncbi.nlm.nih.gov/pmc/art

icles/PMC7197593/

Adepoju P. Tuberculosis and HIV

responses threatened by COVID-19.

The Lancet HIV. 2020;7(5): e319-

e320. https://doi.org/10.1016/S2352-

(20)30109-0

Beima-Sofie, K., Ortblad, K.F.,

Swanson, F. et al. “Keep It Going if

You Can”: HIV Service Provision for

Priority Populations During the

COVID-19 Pandemic in Seattle,

WA. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

McLinden, T., Stover, S. & Hogg, R.S.

HIV and Food Insecurity: A Syndemic

Amid the COVID-19 Pandemic. AIDS

Behav (2020).

https://doi.org/10.1007/s10461-020-

-3

Kay, E.S., Musgrove, K. From HIV to

Coronavirus: AIDS Service

Organizations Adaptative Responses

to COVID-19, Birmingham,

Alabama. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-1

Kowalska J, Skrzat-Klapaczyńska A,

Bursa D, Balayan T, Begovac J,

Chkhartishvili N et al. HIV care in times of the COVID-19 crisis —

Where are we now in Central and

Eastern Europe? International Journal

of Infectious Diseases. 2020; 96: 311-

https://doi.org/10.1016/j.ijid.2020.05.

ONUSIDA. Enfermedad por

Coronavirus (COVID-19) and HIV:

Asuntos y Acciones Claves -

OPS/OMS | Organización

Panamericana de la Salud [Internet].

Paho.org. 2020 [cited 11 June 2020].

Available from:

https://www.paho.org/es/documentos/

enfermedad-por-coronavirus-covid19-and-hiv-asuntos-acciones-claves

Rights in the time of COVID-19 —

Lessons from HIV for an effective,

community-led response [Internet].

Unaids.org. 2020 [cited 15 June 2020].

Available from:

https://www.unaids.org/en/resources/

documents/2020/human-rights-andcovid-19

Wilkinson L, Grimsrud A. The time is

now: expedited HIV differentiated

service delivery during the COVID‐19

pandemic. Journal of the International

AIDS Society. 2020;23(5).

https://doi.org/10.1002/jia2.25503

Eaton L, Kalichman S. Social and

behavioral health responses to

COVID-19: lessons learned from four

decades of an HIV pandemic. Journal

of Behavioral Medicine.

;43(3):341-345.

https://doi.org/10.1007/s10865-020-

-y

Valdiserri, R.O., Holtgrave, D.R.

Responding to Pandemics: What

We’ve Learned from

HIV/AIDS. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-5

Hargreaves J, Davey C, Hargreaves J,

Davey C, Auerbach J, Blanchard J et

al. Three lessons for the COVID-19

response from pandemic HIV. The

Lancet HIV. 2020;7(5): e309-e311.

https://doi.org/10.1016/S2352-

(20)30110-7

Edelman, E.J., Aoun-Barakat, L.,

Villanueva, M. et al. Confronting

Another Pandemic: Lessons from HIV

can Inform Our COVID-19

Response. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-z

Harkness, A., Behar-Zusman, V. &

Safren, S.A. Understanding the Impact

of COVID-19 on Latino Sexual

Minority Men in a US HIV Hot

Spot. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-w

Algarin A, Varas-Rodríguez E,

Valdivia C, Fennie K, Larkey L, Hu N

et al. Symptoms, Stress, and HIVRelated Care Among Older People

Living with HIV During the COVID19 Pandemic, Miami, Florida. AIDS

and Behavior. 2020;1-3.

https://doi.org/10.1007/s10461-020-

-3

Carrico, A.W., Horvath, K.J., Grov,

C. et al. Double Jeopardy:

Methamphetamine Use and HIV as

Risk Factors for COVID-19. AIDS

Behav (2020).

https://doi.org/10.1007/s10461-020-

-w

Joseph Davey, D., Bekker, L., Coates,

T.J. et al. Contracting HIV or Contracting SAR-CoV-2 (COVID19) in Pregnancy? Balancing the Risks

and Benefits. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-x

Joska, J.A., Andersen, L., Rabie, S. et

al. COVID-19: Increased Risk to the

Mental Health and Safety of Women

Living with HIV in South

Africa. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-z

Hightow-Weidman, L., Muessig, K.,

Claude, K. et al. Maximizing Digital

Interventions for Youth in the Midst of

Covid-19: Lessons from the

Adolescent Trials Network for HIV

Interventions. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-w

Rogers, B.G., Coats, C.S., Adams,

E. et al. Development of Telemedicine

Infrastructure at an LGBTQ+ Clinic to

Support HIV Prevention and Care in

Response to COVID-19, Providence,

RI. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-1

Sanchez, T.H., Zlotorzynska, M., Rai,

M. et al. Characterizing the Impact of

COVID-19 on Men Who Have Sex

with Men Across the United States in

April, 2020. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-2

Strategic Considerations for

Mitigating the Impact of COVID-19

on Key- Population-Focused HIV

Programs [Internet]. Unaids.org. 2020

[cited 15 June 2020]. Available from:

https://www.unaids.org/sites/default/fi

les/media_asset/kp-strategicconsiderations-covid19_en.pdf

Operario, D., King, E.J. & Gamarel,

K.E. Prioritizing Community Partners

and Community HIV Workers in the

COVID-19 Pandemic. AIDS

Behav (2020).

https://doi.org/10.1007/s10461-020-

-0

Pinto, R.M., Park, S. COVID-19

Pandemic Disrupts HIV Continuum of

Care and Prevention: Implications for

Research and Practice Concerning

Community-Based Organizations and

Frontline Providers. AIDS

Behav (2020).

https://doi.org/10.1007/s10461-020-

-3

Shoptaw, S., Goodman-Meza, D. &

Landovitz, R.J. Collective Call to

Action for HIV/AIDS CommunityBased Collaborative Science in the Era

of COVID-19. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-y

Ballester-Arnal, R., Gil-Llario, M.D.

The Virus that Changed Spain: Impact

of COVID-19 on People with

HIV. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-3

Marziali, M.E., Card, K.G.,

McLinden, T. et al. Physical

Distancing in COVID-19 May

Exacerbate Experiences of Social

Isolation among People Living with

HIV. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-8

Logie C. Lessons learned from HIV

can inform our approach to COVID‐19

stigma. Journal of the International AIDS Society. 2020;23(5):1-3.

https://doi.org/10.1002/jia2.25504

Krier, S., Bozich, C., Pompa, R. et

al. Assessing HIV-Related Stigma in

Healthcare Settings in the Era of the

COVID-19 Pandemic, Pittsburgh,

Pennsylvania. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-4

Logie, C.H., Turan, J.M. How Do We

Balance Tensions Between COVID-19

Public Health Responses and Stigma

Mitigation? Learning from HIV

Research. AIDS Behav (2020).

https://doi.org/10.1007/s10461-020-

-8

Villanueva S. Infecciones y estigmas:

lecciones de la pandemia del VIH para

el mañana de la COVID-19 [Internet].

The Conversation. 2020 [cited 10 June

. Available from:

https://theconversation.com/infeccion

es-y-estigmas-lecciones-de-lapandemia-del-vih-para-el-manana-dela-covid-19-135522

Relf MV. What's Old is New!

Similarities Between SARS-CoV-2

and HIV. J Assoc Nurses AIDS Care.

;31(3):263‐265.

https://doi.org/10.1097/jnc.000000000